Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Τhe Combination of Pharmacotherapy With RECOVERYTRSGR and RECOVERYTRSBDGR. — Stella

Home/Treatment Resistant Schizophrenia/

View on ClinicalTrials.gov

Recruiting

Back to Treatment Resistant Schizophrenia trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

Greece

Private practice of Dr. S. Rakitzi and Dr. P. Georgila ILISION 34 15771 ATHENS GREECE, Athens

Key details

Phase

Post-approval study

Sponsor

Dr. Stavroula Rakitzi

Enrollment target

~40 participants

Started

June 2025

Primary completion

December 2027

Age range

18 Years – 65 Years

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.